AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase
- 31 December 2004
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 63 (2) , 328-333
- https://doi.org/10.1016/j.mehy.2004.01.044
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular eventsCurrent Opinion in Cardiology, 2003
- Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular diseaseAmerican Heart Journal, 2003
- Pioglitazone Improves Insulin Sensitivity Among Nondiabetic Patients With a Recent Transient Ischemic Attack or Ischemic StrokeStroke, 2003
- Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse modelsBiochemical Society Transactions, 2003
- Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention studyEuropean Journal of Clinical Nutrition, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- INDUCED NITRIC OXIDE INHIBITS IL-6-INDUCED STAT3 ACTIVATION AND TYPE II ACUTE PHASE MRNA EXPRESSIONShock, 2000
- High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetesMedical Hypotheses, 1999
- Acute Sympathoinhibitory Actions of Metformin in Spontaneously Hypertensive RatsHypertension, 1996
- Biotin Enhances Guanylate Cyclase ActivityScience, 1982